NCT02556775View on ClinicalTrials.gov

Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

December 4, 2015

Primary Completion Date

December 17, 2019

Study Completion Date

December 17, 2019

Conditions
Exposure During Pregnancy
Interventions
BIOLOGICAL

A licensed human normal immunoglobulin other than HYQVIA for IV or SC infusion or an alternative treatment

To be determined by the physician

BIOLOGICAL

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]

Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase

Trial Locations (8)

10034

Fakultni nemocnice Kralovske Vinohrady, Prague

27703

QuintilesIMS Plaza Building, Durham

79108

Freiburg University Hospital/ Prof. Dr. med. Bodo Grimbacher, Freiburg im Breisgau

81250

Onkologicky ustav svatej Alzbety s.r.o., Bratislava

97080

Universitaetsklinikum Wuerzburg, Würzburg

04129

Klinikum St. Georg GmbH, Leipzig

04-141

Wojskowy Instytut Medyczny, Warsaw

04001

RAFMED s.r.o, Košice

All Listed Sponsors
collaborator

Baxalta Innovations GmbH, now part of Shire

INDUSTRY

lead

Baxalta now part of Shire

INDUSTRY

NCT02556775 - Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia | Biotech Hunter | Biotech Hunter